UPAR mimicking peptide
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 8, 2002
Grant Date -
N/A
app pub date -
Oct 20, 1999
filing date -
Mar 20, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Peptides comprising the SRSRY sequence (SEQ ID NO: 7) derived from the uPAR (urokinase receptor) are endowed with chemotactic activity, making them useful for preventing or activating the migration of cells in a mammal. More particularly, the peptides of the invention are useful for the treatment of cancer, autoimmune diseases, and/or hyperinflammatory diseases and for stimulating wound healing.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully